These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12404911)

  • 41. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
    J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nicotine-antipsychotic drug interactions and attentional performance in female rats.
    Rezvani AH; Levin ED
    Eur J Pharmacol; 2004 Feb; 486(2):175-82. PubMed ID: 14975706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
    Dunner DL
    J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms?
    Arana GW; Goff DC; Friedman H; Ornsteen M; Greenblatt DJ; Black B; Shader RI
    Am J Psychiatry; 1986 May; 143(5):650-1. PubMed ID: 3963258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical application of the concept of relative potency: an example involving chlorpromazine and haloperidol.
    Preskorn SH
    J Psychiatr Pract; 2005 Jul; 11(4):258-61. PubMed ID: 16041236
    [No Abstract]   [Full Text] [Related]  

  • 46. Lithium and neuroleptics in combination: is there enhancement of neurotoxicity leading to permanent sequelae?
    Goldman SA
    J Clin Pharmacol; 1996 Oct; 36(10):951-62. PubMed ID: 8930783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of bipolar disorders].
    Schmauss M; Messer T
    MMW Fortschr Med; 2009 Mar; 151(13):74-8. PubMed ID: 19504825
    [No Abstract]   [Full Text] [Related]  

  • 48. Interindividual variation of plasma haloperidol concentrations and the impact of concomitant medications: the analysis of therapeutic drug monitoring data.
    Hirokane G; Someya T; Takahashi S; Morita S; Shimoda K
    Ther Drug Monit; 1999 Feb; 21(1):82-6. PubMed ID: 10051058
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carbamazepine extended-release capsules use in bipolar disorder: efficacy and safety in adult patients.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():9-14. PubMed ID: 16754406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction between carbamazepine and bromperidol.
    Otani K; Ishida M; Yasui N; Kondo T; Mihara K; Suzuki A; Furukori H; Kaneko S; Inoue Y
    Eur J Clin Pharmacol; 1997; 52(3):219-22. PubMed ID: 9218929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pitch perception shift: a rare side-effect of carbamazepine.
    Kobayashi T; Nisijima K; Ehara Y; Otsuka K; Kato S
    Psychiatry Clin Neurosci; 2001 Aug; 55(4):415-7. PubMed ID: 11442894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hormone modulation: a novel therapeutic approach for women with severe mental illness.
    Kulkarni J; Gurvich C; Gilbert H; Mehmedbegovic F; Mu L; Marston N; Gavrilidis E; de Castella A
    Aust N Z J Psychiatry; 2008 Jan; 42(1):83-8. PubMed ID: 18058448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reversible posterior leukoencephalopathy syndrome after withdrawal of antipsychotic medication in the context of lithium intoxication.
    Loens S; Conzen J; Welte GS; Scharn N; Schrader C; Weissenborn K
    Gen Hosp Psychiatry; 2015; 37(3):274.e3-5. PubMed ID: 25794475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Do enzyme inducers modify haloperidol decanoate rate of release?
    Pupeschi G; Agenet C; Levron JC; Barges-Bertocchio MH
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):1323-32. PubMed ID: 7863019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A case of delayed galactorrhoea as an adverse event of overlapping haloperidol and clozapine administration.
    Conca A; Waler M; Walpoth M; König P; Hausmann A
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):303-5. PubMed ID: 15850503
    [No Abstract]   [Full Text] [Related]  

  • 56. [Acute encephalomyopathy and persistent cerebellar syndrome after lithium salt and haloperidol poisoning].
    Gille M; Ghariani S; Piéret F; Delbecq J; Depré A; Saussu F; de Barsy T
    Rev Neurol (Paris); 1997 May; 153(4):268-70. PubMed ID: 9296146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity.
    Spina E; Scordo MG; Avenoso A; Perucca E
    J Clin Psychopharmacol; 2001 Feb; 21(1):108-9. PubMed ID: 11199933
    [No Abstract]   [Full Text] [Related]  

  • 58. Haloperidol-induced ileus.
    Sirois FJ
    Psychosomatics; 2005; 46(3):275-6. PubMed ID: 15883151
    [No Abstract]   [Full Text] [Related]  

  • 59. Antipsychotic drugs, lithium, carbamazepine, and abnormal diurnal weight gain in psychosis.
    Vieweg V; Godleski L; Hundley P; Harrington D; Yank G
    Neuropsychopharmacology; 1989 Mar; 2(1):39-43. PubMed ID: 2572232
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Absence of carbamazepine-induced hyponatremia among patients also given lithium.
    Vieweg V; Glick JL; Herring S; Kerler R; Godleski LS; Barber J; Yank G; Spradlin W
    Am J Psychiatry; 1987 Jul; 144(7):943-7. PubMed ID: 3605408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.